FCH
DVAX

Freestone Capital Holdings’s Dynavax Technologies DVAX Stock Holding History

Freestone Capital Holdings’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-100
Closed -$445 – 580
2020
Q4 		$445 Hold
100
– – ﹤0.01% 1262
2020
Q3 		$432 Buy
+100
New +$714 ﹤0.01% 1175

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Freestone Capital Holdings's DVAX Position: Q1 2021 in Review

Freestone Capital Holdings sold out of Dynavax Technologies (DVAX) in Q1 2021, closing a stake of 100 shares — an estimated $445 sold.

Freestone Capital Holdings first reported a position in DVAX in Q3 2020 and held it in 2 quarters. The position peaked at $445 in Q4 2020. 162 funds tracked by Wall St. Rank hold DVAX as of Q1 2021.

  • Freestone Capital Holdings reported no remaining Dynavax Technologies position as of Q1 2021 after selling out during the quarter.
  • Freestone Capital Holdings sold 100 Dynavax Technologies shares in Q1 2021, an estimated $445.
  • Freestone Capital Holdings first reported a position in Dynavax Technologies in Q3 2020 and held it in 2 quarters.
  • Freestone Capital Holdings's Dynavax Technologies position peaked at $445 in Q4 2020.
  • 162 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2021.

Based on Freestone Capital Holdings's 13F filing for Q1 2021, filed 17 May 2021.